Malaria control and elimination requires a multifaceted approach. Right now we have a good set of tools, including insecticide sprays and long-lasting insecticide-treated mosquito nets that help prevent transmission by mosquitoes. But no prevention strategy is 100% effective - there will always be instances of network intrusion. The current WHO-recommended treatment for the majority of malaria cases is artemisinin-based combination therapy (ACT). These drugs, along with diagnostics, are available to treat and in some cases prevent malaria.
Guidelines for the treatment of malaria:
Malaria treatment depends on the type of malaria, as well as the severity of the disease. The World Health Organization's guidelines for treating malaria provide recommendations on topics such as:
* Uncomplicated treatment p. Falciparum malaria
* Treatment for uncomplicated malaria caused by p. Vivax
* Treating severe malaria
* Collective drug administration
* .... and more
Developing effective antimalarials to save lives:
The MMV portfolio focuses on providing effective, affordable, available and suitable medicines for use in malaria endemic areas. Specifically, the goal is to develop products that provide: efficacy against drug-resistant strains of P. falciparum, possibility of intermittent therapy (infants and pregnancy), safety in young children (<6 months), safety during pregnancy, and efficacy against P. That radical treatment), effectiveness against acute malaria, and treatment to prevent transmission.
Facilitating delivery of new, effective and affordable antimalarial drugs:
The Access and Product Management (APM) team at MMV ensures that innovative new antimalarials emerging from our pipeline reach those in need and save lives.
EmoticonEmoticon